News

Clinical trials on the horizon for experimental cancer drug.

For the first time, scientists from the Florida campus of The Scripps Research Institute (TSRI) have created detailed “fingerprints” of a class of surface receptors that have proven highly useful for drug development.

Flexible processing of pre-sterilized syringes.

Novo Nordisk acquires exclusive global rights to XMetA program for the treatment of diabetes.

Healthcare Packaging plant will produce moisture-control products.

A mobility enabled software solution specifically designed for the Transport and Logistics (T&L) sector.

Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has been acquired by specialist healthcare investor GHO Capital, with financial details of the transaction remaining undisclosed.

Researchers at North Carolina State University and the University of North Carolina at Chapel Hill have developed a new drug delivery technique that uses a biodegradable liquid metal to target cancer cells.

Fraunhofer scientists use the gel-like mass from Chilean seaweed as the substrate for stem cells.

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have announced a collaboration focused on developing innovative medicines for pancreatic ductal adenocarcinoma (PDAC).